the effect of cognitive-behavioral training along with motivational interviewing in comparison with cognitive-behavioral training on depression, medication adherence and level of hemoglobin A1C in type 2 diabetic patients with depression signs

The effect of cognitive-behavioral education combined with motivational interviewing in comparison with cognitive-behavioral education on depression, drug adherence and hemoglobin A1C in patients with type 2 diabetes with depressive symptoms

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160924029954N14

Enrollment

Registered

2020-11-23

Start date

2020-08-31

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diabetic patients. Condition 2: depressive disorder. Diabetes mellitus due to underlying condition Major depressive disorder, single episode

Interventions

Intervention 1: Intervention group: Intervention procedure: 1: Cognitive-behavioral training with motivational interview: 8 sessions of cognitive-behavioral training with motivational interview Three

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Hemoglobin a1c in the amount of 8 and more Obtaining a score of 21 from the Beck Depression Inventory and confirming depression in the mental state examination No other psychiatric illnesses 6 months to 1 year of illness Full consciousness and no communication problem No addiction and substance abuse No history of participating in a counseling or training rehabilitation program at the same time Willingness to participate in the study Diagnosis of type 2 diabetes based on the patient's record Age range 20 to 60 years

Exclusion criteria

Exclusion criteria: Critical illness, hospitalization, death, or any unexpected events during the study Do not attend more than one treatment session

Design outcomes

Primary

Measure	Time frame
People whose Beck questionnaire score is above 21. Timepoint: "Measurement of depression at the beginning of the study and 3 months after the intervention". Method of measurement: Beck Depression Inventory.;The score they get from the Drug Adherence Questionnaire. Timepoint: Measurement of drug adherence at the beginning of the study and three months after the intervention. Method of measurement: Moriski Drug Adherence Questionnaire.;Percentage of globin a1c reported by the laboratory. Timepoint: Measurement of hemoglobin a1c at the beginning of the study and three months after the intervention. Method of measurement: Laboratory measurement of hemoglobin a1c.	—

Measure

Time frame

People whose Beck questionnaire score is above 21. Timepoint: "Measurement of depression at the beginning of the study and 3 months after the intervention". Method of measurement: Beck Depression Inventory.;The score they get from the Drug Adherence Questionnaire. Timepoint: Measurement of drug adherence at the beginning of the study and three months after the intervention. Method of measurement: Moriski Drug Adherence Questionnaire.;Percentage of globin a1c reported by the laboratory. Timepoint: Measurement of hemoglobin a1c at the beginning of the study and three months after the intervention. Method of measurement: Laboratory measurement of hemoglobin a1c.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Miri

Zahedan University of Medical Sciences

mirizahra174@gmail.com+98 54 3721 2364

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026